Some people find that taking their tablets at the same time each day, following their doctors instructions, is helpful
Who Might Benefit From Dual-Compound Semaglutide and Tirzepatide Therapy Patients who benefit most from dual-compound GLP-1 protocols typically have high baseline weight, comorbid type 2 diabetes, a family history of metabolic disease, or prior inadequate response to single-agent therapy
Semaglutide belongs to a class called GLP-1 receptor agonists the same category that includes Ozempic, Wegovy, and even tirzepatide medications like Mounjaro and Zepbound
11 As for physical activity , it gets your gut moving, which can help offset any slowdowns in digestion that might come with using Wegovy
Slowing Gastric Emptying: Semaglutide slows down how quickly food leaves your stomach